0001213900-23-002248.txt : 20230111 0001213900-23-002248.hdr.sgml : 20230111 20230111154213 ACCESSION NUMBER: 0001213900-23-002248 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230109 FILED AS OF DATE: 20230111 DATE AS OF CHANGE: 20230111 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lumira Capital Investment Management Inc. CENTRAL INDEX KEY: 0001702636 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37619 FILM NUMBER: 23523542 BUSINESS ADDRESS: STREET 1: 141 ADELAIDE STREET WEST STREET 2: SUITE 770 CITY: TORONTO STATE: A6 ZIP: M5H 3L5 BUSINESS PHONE: 416-213-4223 MAIL ADDRESS: STREET 1: 141 ADELAIDE STREET WEST STREET 2: SUITE 770 CITY: TORONTO STATE: A6 ZIP: M5H 3L5 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: van der Velden Peter CENTRAL INDEX KEY: 0001778046 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37619 FILM NUMBER: 23523543 MAIL ADDRESS: STREET 1: C/O EDESA BIOTECH INC. STREET 2: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edesa Biotech, Inc. CENTRAL INDEX KEY: 0001540159 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 BUSINESS PHONE: (905) 475-1234 MAIL ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 FORMER COMPANY: FORMER CONFORMED NAME: Stellar Biotechnologies, Inc. DATE OF NAME CHANGE: 20120120 4 1 ownership.xml X0306 4 2023-01-09 1 0001540159 Edesa Biotech, Inc. EDSA 0001778046 van der Velden Peter 770-141 ADELAIDE STREET WEST TORONTO A6 M5H 3L5 ONTARIO, CANADA 0 0 1 0 0001702636 Lumira Capital Investment Management Inc. 770-141 ADELAIDE STREET WEST TORONTO A6 M5H 3L5 ONTARIO, CANADA 0 0 1 0 Common share 2023-01-09 4 S 0 132845 2.6621 D 1764583 I Held by Lumira Capital II, L.P. Common share 2023-01-09 4 S 0 12284 2.6621 D 163170 I Held by Lumira Capital II (International), L.P. Common share 2023-01-10 4 S 0 139450 2.6346 D 1625133 I Held by Lumira Capital II, L.P. Common share 2023-01-10 4 S 0 12895 2.6346 D 150275 I Held by Lumira Capital II (International), L.P. This Form 4 is jointly filed by (i) Lumira Capital II, L.P. ("LCII LP"), (ii) Lumira Capital II (International), L.P. ("LCII INT LP"), (iii) Lumira Capital GP, L.P., (iv) Lumira GP Inc. (v) Lumira GP Holdings Co., and (vi) Lumira Capital Investment Management Inc. Lumira Capital GP, L.P. the general partners of which are Lumira GP Inc. and Lumira GP Holdings Co., is the general partner of LCII LP and LCII INT LP, and each of LCII LP and LCII INT LP is managed by Lumira Capital Investment Management Inc. Mr. van der Velden is an executive officer of Lumira GP Inc., Lumira GP Holdings Co., and Lumira Capital Investment Management Inc. Each of Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc. and Mr. van der Velden may be deemed to beneficially own the shares held by LCII LP and LCII INT LP, but each disclaim beneficial ownership except to the extent of their pecuniary interest therein, if any. /s/ Peter van der Velden 2023-01-11 Lumira Capital Investment Management Inc.: by: /s/ Vasco Larcina, CFO 2023-01-11